Steven B. Ketchum - Aug 2, 2021 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)

Role
Chief Scientific Officer
Signature
/s/ Michael W. Kalb, by power of attorney
Stock symbol
AMRN
Transactions as of
Aug 2, 2021
Transactions value $
$0
Form type
4
Date filed
8/4/2021, 08:02 PM
Previous filing
Aug 3, 2021
Next filing
Sep 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRN Stock Option (Right to Buy) Award $0 +96.8K $0.00 96.8K Aug 2, 2021 Ordinary Shares 96.8K $4.22 Direct F1, F2
transaction AMRN Restricted Stock Units Award $0 +71.7K $0.00 71.7K Aug 2, 2021 Ordinary Shares 71.7K $0.00 Direct F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 2, 2021, the Reporting Person was granted an option to purchase 96,750 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each October, January, April and July.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
F4 On August 2, 2021, the Reporting Person was granted 71,650 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of July 31, 2022, July 31, 2023 and July 31, 2024.
F5 Not applicable.

Remarks:

The equity grants referenced above were supported by recommendations of the Company's independent compensation consultant and approved by the Remuneration Committee of the Company's Board of Directors. In the case of a Change of Control (as defined in the Issuer's stock incentive plan), the grants described in this Form 4 vest in full. As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 1,415,354 Ordinary Shares of the Issuer in the form of Ordinary Shares, stock options and RSUs outstanding under the Issuer's stock incentive plans, including but not limited to certain performance-based RSUs that are earned only if certain pre-defined operational milestones are achieved and, in certain cases, then vest only if the recipient remains with the company for an extended period of time.